Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 20624 | Pitolisant HCl | 903576-44-3 | 98% Min. |  |
| Pitolisant, also known as Tiprolisant, BF2649 and Ciproxidine, is a histamine recepto | ||||
| 20618 | Pirtobrutinib | 2101700-15-4 | 98% Min. |  |
| 20613 | PLX8394 | 1393466-87-9 | 98% Min. | _1393466-87-9.png) |
| PLX8394 is an orally bioavailable inhibitor of serine/threonine-protein kinase B-raf | ||||
| 20593 | Pyrrole-3-carboxaldehyde | 7126 -39-8 | 98% Min. | |
| 231106 | PDS-0330 | 2904682-19-3 | ≧98.0% |  |
| PDS0330 is a new claudin-1 inhibitor in Colorectal Cancer. | ||||
| 20548 | Pimicotinib ( ABSK02 ) | 2253123-16-7 | ≧98.0% |  |
| Pimicotinib is a novel small molecule inhibitor of CSF-1R, which is orally available, | ||||
| 20527 | PF-9363 | 98% Min. |  | |
| 20511 | PDD4091 | 1373651-41-2 | ≧98.0% |  |
| PDD4091 is a novel G6PD inhibitor. | ||||
| 20500 | PD089828 | 179343-17-0 | 98% Min. |  |
| PD089828 is a potent FGFR inhibitor, which inhibits human full-length fibroblast grow | ||||
| 20499 | PD-173955 | 260415-63-2 | 98% Min. |  |
| PD-173955 is a src tyrosine kinase inhibitor. PD173955 inhibited Bcr-Abl-dependent ce | ||||
| 20481 | 4-Pyrimidinol, 6-cyclopropyl- (7CI,8CI) | 7038-75-7 | 98% Min. | _7038-75-7.png) |
| 20468 | PD-173212 | 217171-01-2 | 98% Min. |  |
| PD-173212 is a small molecule N-type calcium channel blocker. PD173212 fully reduced | ||||
| 20432 | 2-Pyridinamine, 3-(difluoromethoxy)-5-[2-(3,3-difluoro-1-pyrrolidinyl)-6-(1S,4S)-2-oxa-5-azabicyclo[2.2.1]hept-5-yl-4-pyrimidinyl]- | 1637394-01-4 | 98% Min. | -5-[2-(3,3-difluoro-1-pyrrolidinyl)-6-(1S,4S)-2-oxa-5-azabicyclo[2.2.1]hept-5-yl-4-pyrimidinyl]-_1637394-01-4.png) |
| 171458 | Pyrido[2,3-d]pyrimidin-2(1H)-one, 1-[2-cyclobutyl-6-(methylsulfonyl)phenyl]-4-[(2S,5R)-2,5-dimethyl-4-(1-oxo-2-propen-1-yl)-1-piperazinyl]-6-fluoro-7-(2-fluoro-6-hydroxyphenyl)- | 2670380-82-0 | 98% Min. | -one,_1-[2-cyclobutyl-6-(methylsulfonyl)phenyl]-4-[(2S,5R)-2,5-dimethyl-4-(1-oxo-2-propen-1-yl)-1-piperazinyl]-6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-.png) |
| 171457 | 2-Pyridinecarboxylic acid, 4,5,6-trichloro-, methyl ester | 496849-76-4 | 98% Min. |  |
| 20399 | 5-(1-propyloxy)-pyrrolidin-2-one | 111712-03-9 | 98% Min. | -pyrrolidin-2-one_111712-03-9.png) |
| G20374 | 1-Piperazinecarboxylic acid, 2-methyl-5-oxo-, 1,1-dimethylethyl ester, (2S)- | 1627749-02-3 | 98% Min. |  |
| 20367 | Piflufolastat | 1423758-00-2 | ≧96% |  |
| Piflufolastat, also known as DCFPYL is a PSMA-targeted PET imaging agent for prostate | ||||
| L20351 | PFM01 | 1558598-41-6 | 98% Min. |  |
| PFM01 is a nuclease-specific MRE11 inhibitor. PFM01 targets MRE11 at a site near the | ||||
| L20349 | Poloxin | 321688-88-4 | 98% Min. |  |
| Poloxin is the first small-molecule inhibitor specifically targeting the function of | ||||
| L20345 | Prexasertib free base | 1234015-52-1 | 98% Min. |  |
| Prexasertib, also know LY2606368, is a n inhibitor of checkpoint kinase 1 (chk1) with | ||||
| L20333 | Parsaclisib HCl | 1995889-48-9 | 98% Min. |  |
| Parsaclisib, also known as INCB050465, is a novel PI3Kδ inhibitor which synergizes w | ||||
| L20332 | Parsaclisib free base | 1426698-88-5 | 98% Min. |  |
| Parsaclisib, also known as INCB050465, is a novel PI3Kδ inhibitor which synergizes w | ||||
| 20294 | Paltusotine ( CRN-00808 ) | 2172870-89-0 | ≧98.0% |  |
| Paltusotine is a new class of oral, selective, nonpeptide, somatostatin receptor type | ||||
| 20282 | PS210 | 1221962-86-2 | 98% Min. |  |
| PS210 is a substrate-selective inhibitor of protein kinase PDK1. It acts by binding t | ||||
| 20278 | PD-159206 | 171744-42-6 | ≧94.0% |  |
| PD-159206 is a nucleocapsid inhibitor. It exhibits good antiviral activity against HI | ||||
| 21251 | PF-06882961 | 2230198-02-2 | 98% Min. |  |
| PF-06882961 is a potent, orally bioavailable agonist of the glucagon-like peptide-1 r | ||||
| 21227 | 3PO | 18550-98-6 | 98% Min. |  |
| 3PO is a PFKFB3 (6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase) inhibitor. 3PO | ||||
| 2073108 | PF-06802861 ( ARRY 371797 ; ARRY-797 ) | 1034189-82-6 | ≧98.0% |  |
| ARRY 797 (also known as ARRY 371797 or PF 06802861) is an orally active, selective p3 | ||||
| 2071623 | PF-04745637 | 1917294-46-2 | 98% Min. |  |
| PF-04745637 is a TRPV1 antagonist. | ||||